Global Markets for Treatments for Syndromes of Dementia and Movement Disorders

Published - Sep 2012| Analyst - Shalini Shahani Dewan| Code - PHM117A
Market Research Report Single User License: $3325

Report Highlights

The global market for treatments for syndromes of dementia and movement disorders was valued at 10.5 billion in 2011 and should reach $11.1 billion in 2012. Total market value is expected to reach $16.7 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8.5%.

SCOPE OF THE STUDY

The scope of this study encompasses the neurodegenerative disorders in the pharmaceutical and biotechnology markets.  BCC analyzes each market and its applications, regulatory environment, technology involved, market projections and market share.  Technological issues include the latest trends and developments.  The emerging market for enzyme inhibitors includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia, New Zealand and Mexico.

ABOUT THE AUTHOR

The study has been carried out by a team of professionals in the biotechnology industry.  The project manager for this study is Shalini S. Dewan, who holds a master’s degree in pharmaceutical chemistry and has more than 14 years of industry experience.  Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid.  Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S.

Some of her other reports with BCC include Reagents for Chromatography; Spectroscopy—An Enduring Market; Advanced Drug Delivery Systems—Technologies and Global Markets; Orthopedic Drugs, Implants and Devices—Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry—The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging—Global Markets; Chiral Technology—Global Markets; Autacoids and Related Drugs—Technologies and Global Markets; Contraceptives—Technologies and Global Markets; Liver Disease Treatments—The Global Market; Hormone Replacement Therapies and Other Hormone Therapies—Global Markets; Cardiovascular Medicine—Diagnostics, Drugs and Devices; and Cancer Therapies − Technologies and Global Markets.

The lead consultant on this project is Ms. Ruma Chakravarty, who holds a master’s degree in biophysics.  She has tremendous experience in market research, quality, process improvement and lean and six sigma concepts.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at(+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter Name Pages Price
Full Report: Global Markets for Treatments for Syndromes of Dementia and Movement Disorders 228 $3325
Chapter- 1: INTRODUCTION 3
Chapter- 2: EXECUTIVE SUMMARY 2 $250
Chapter- 3: OVERVIEW 10 $219
Chapter- 4: REGULATORY ASPECTS 5 $109
Chapter- 5: NEW DEVELOPMENTS 19 $416
Chapter- 6: GLOBAL MARKETS 13 $284
Chapter- 7: MARKET FOR DRUG PRODUCTS USED TO TREAT PROGRESSIVE DEMENTIA 32 $700
Chapter- 8: MARKET FOR DRUGS TO TREAT PROGRESSIVE DEMENTIA WITH OTHER NEUROLOGICAL ABNORMALITIES 24 $525
Chapter- 9: MARKET FOR MOVEMENT DISORDER SYNDROMES 35 $766
Chapter- 10: PATENT ANALYSIS 20 $438
Chapter- 11: CURRENT SITUATION 7 $153
Chapter- 12: COMPANY PROFILES 55 $1203
Chapter- 13: APPENDIX I: ABBREVIATIONS 3 $66
List of Tables
List of Figures
Download Table of Contents
RELATED REPORTS
Share This Report